Immunome, Inc.
USD21.04
+1.08 (+5.41%)
CEO
Clay Siegall
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$20.15
Prev. Close
$19.96
Day Low
$19.65
Day High
$21.10
52W Low
$7.96
52W High
$27.65
Market Cap
$2.01B
Volume
1.57M
| -2.1 |
| 31 Dec 2023 | FY | 100.0% | -761.9% | -89.1% | -71.9% | 0.01 | 6.63 | -2.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -221.6% | -153.4% | 0.02 | 3.09 | -0.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -51.3% | -42.7% | 0.01 | 5.82 | -6.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -43.1% | -40.1% | 0.01 | 14.12 | -5.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 29.6% | -208.5% | -0.02 | 1.88 | -7.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 31.1% | -176.4% | -0.05 | 1.35 | -1.9 |
| -6.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -21.8% | -19.2% | 0.02 | 8.90 | -4.5 |
| 30 Jun 2025 | Q2 | 82.1% | -1080.9% | -16.1% | -14.6% | 0.02 | 12.13 | -4.7 |
| 31 Mar 2025 | Q1 | 100.0% | -1423.1% | -13.6% | -12.2% | 0.02 | 10.49 | -3.2 |
| 31 Dec 2024 | Q4 | 100.0% | -2930.9% | -44.3% | -33.4% | 0.03 | 4.08 | -2.1 |
| 30 Sept 2024 | Q3 | 100.0% | -1618.6% | -21.9% | -18.3% | 0.01 | 6.17 | -4.7 |
| 30 Jun 2024 | Q2 | 100.0% | -1528.0% | -14.2% | -12.2% | 0.01 | 7.12 | -5.1 |
| 31 Mar 2024 | Q1 | 100.0% | -12584.3% | -45.3% | -40.5% | 0.01 | 10.18 | -0.4 |
| 31 Dec 2023 | Q4 | 100.0% | -2421.2% | -77.3% | -62.4% | 0.01 | 6.63 | -0.6 |